# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Pemphigus foliaceus

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-5 of 5 results.
A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus
Status: Recruiting
Last Changed: Aug 29, 2019
First Received: Nov 07, 2017
Disease(s): Pemphigus Vulgaris, Pemphigus Foliaceus
Intervention(s): ARGX-113
Locations: University of Lübeck and UKSH, Department of Dermatology and Lübeck Institute of Experimental Dermatology, Lübeck, Germany
Clinic of Dermatology and Allergology - Philipps University Marburg, Marburg, Germany
University of Debrecen Medical Center Department of Dermatology, Debrecen, Hungary
University of Pécs Clinical Center , Department of Dermatology, Venerology and Oncodermatology, Pécs, Hungary
University of Szeged Faculty of Medicine Albert Szent-Györgyi Medical Center Department of Dermatology and Allergology, Szeged, Hungary
... and 8 other locations.
Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Status: Recruiting
Last Changed: Jul 17, 2019
First Received: Aug 04, 2017
Disease(s): Pemphigus Foliaceus, Pemphigus Vulgaris
Intervention(s): Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs
Locations: University of California San Francisco School of Medicine: Department of Dermatology, San Francisco, California, United States
University of Iowa Health Care: Department of Dermatology, Iowa City, Iowa, United States
Duke University Medical Center: Department of Dermatology, Durham, North Carolina, United States
University of Texas Southwestern Medical Center: Department of Dermatology, Dallas, Texas, United States
A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
Status: Recruiting
Last Changed: Aug 23, 2018
First Received: Mar 09, 2017
Disease(s): Pemphigus, Pemphigus Vulgaris, Pemphigus Foliaceus
Intervention(s): SYNT001
Locations: Syntimmune Study Site, Palo Alto, California, United States
Syntimmune Study Site, Atlanta, Georgia, United States
Syntimmune Study Site, Buffalo, New York, United States
Syntimmune Study Site, Chapel Hill, North Carolina, United States
Syntimmune Study Site, Durham, North Carolina, United States
... and 3 other locations.
Autoimmune Blistering Diseases Study
Status: Recruiting
Last Changed: Apr 11, 2019
First Received: Apr 28, 2016
Disease(s): Pemphigus Vulgaris, Pemphigus Foliaceus, Bullous Pemphigoid
Intervention(s): Questionnaires
Locations: Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia, Pennsylvania, United States
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Pennsylvania, Department of Dermatology, Philadelphia, Pennsylvania, United States
A Study of PRN1008 in Patients With Pemphigus
Status: Recruiting
Last Changed: Aug 01, 2019
First Received: Dec 03, 2018
Disease(s): Pemphigus
Intervention(s): PRN1008 Oral Tablet, Placebo Oral Tablet
Locations: Central Recruiting, Boca Raton, Florida, United States
Central Recruiting (Principia Biopharma), Coral Gables, Florida, United States
Central Recruiting, Atlanta, Georgia, United States
Central Recruiting, Ann Arbor, Michigan, United States
Central Recruiting, Rochester, Minnesota, United States
... and 30 other locations.